Prostate cancer in the black community and the importance of clinical trials

In recognition of Prostate Cancer Awareness Month in September, BLACK ENTERPRISES hosts “Health is Wealth,” an informative series of conversations about the key role of diversity in clinical trials. Prostate cancer disproportionately affects black men, resulting in significant disparities in health outcomes, quality of life, and longevity. This discussion highlights the importance of inclusive clinical trials in eliminating these disparities.

Alfred Edmond Jr.Black EnThe conversation might be moderated by the vp and editor-in-chief of terprise and a prostate cancer survivor. Edmond might be joined by experts in the field, Dr. Adrelia Allen, executive director of patient diversity in clinical trials at Merck, and Dr. Luther T. Clark, executive director of innovation and patient engagement at Merck, and Euvon Jonesformer clinical trial participant and prostate cancer advocate.

This panel examined how clinical trials might help improve prostate cancer outcomes in black men, highlight the importance of diversity in medical research, and encourage participation in future research to support equitable health take care of all. The discussion will highlight Merck’s commitment to improving prostate cancer treatments by supporting diverse and inclusive clinical trials, ensuring equal access to the latest medical innovations for historically underserved populations.

Prostate cancer disproportionately affects black men, resulting in higher mortality and poorer health outcomes in comparison with other groups.

Post views: 59